Markers of squamous cell carcinoma in sarco/endoplasmic reticulum Ca2+ ATPase 2 heterozygote mice keratinocytes

Progress in Biophysics and Molecular Biology

Volumn 103, Issue 1, 2010, Pages 81-87

  Hong, Jeong Hee ^a   Yang, Yu Mi ^a   Kim, Hyun Sil ^a   Lee, Syng Ill ^a   Muallem, Shmuel ^b   Shin, Dong Min ^a  

^a Yonsei University College of Dentistry   (South Korea)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Keratinocytes; Squamous cell carcinoma

Indexed keywords

MUS;

EID: 77955268552     PISSN: 00796107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbiomolbio.2009.10.005     Document Type: Review

References (34)

1. Ahn W., Lee M.G., Kim K.H., Muallem S. Multiple effects of SERCA2b mutations associated with Darier's disease. J. Biol. Chem. 2003, 278:20795-20801.
2. Berhane T., Halliday G.M., Cooke B., Barnetson R.S. Inflammation is associated with progression of actinic keratoses to squamous cell carcinomas in humans. Br. J. Dermatol. 2002, 146:810-815.
3. Bikle D.D., Ng D., Tu C.L., Oda Y., Xie Z. Calcium- and vitamin D-regulated keratinocyte differentiation. Mol. Cell Endocrinol. 2001, 177:161-171.
4. Bollimuntha S., Ebadi M., Singh B.B. TRPC1 protects human SH-SY5Y cells against salsolinol-induced cytotoxicity by inhibiting apoptosis. Brain Res. 2006, 1099:141-149.
5. Bollimuntha S., Singh B.B., Shavali S., Sharma S.K., Ebadi M. TRPC1-mediated inhibition of 1-methyl-4-phenylpyridinium ion neurotoxicity in human SH-SY5Y neuroblastoma cells. J. Biol. Chem. 2005, 280:2132-2140.
6. Chang H., Iizasa T., Shibuya K., Iyoda A., Suzuki M., Moriya Y., Liu T.L., Hiwasa T., Hiroshima K., Fujisawa T. Increased expression of collagen XVIII and its prognostic value in nonsmall cell lung carcinoma. Cancer 2004, 100:1665-1672.
7. Chen J., He Q.Y., Yuen A.P., Chiu J.F. Proteomics of buccal squamous cell carcinoma: the involvement of multiple pathways in tumorigenesis. Proteomics 2004, 4:2465-2475.
8. Elias P.M., Ahn S.K., Denda M., Brown B.E., Crumrine D., Kimutai L.K., Komuves L., Lee S.H., Feingold K.R. Modulations in epidermal calcium regulate the expression of differentiation-specific markers. J. Invest. Dermatol. 2002, 119:1128-1136.
9. Foggia L., Hovnanian A. Calcium pump disorders of the skin. Am. J. Med. Genet. C Semin. Med. Genet. 2004, 131C:20-31.
10. Fujita T., Matsumoto Y., Hirai I., Ezoe K., Saito T., Yagihashi A., Torigoe T., Homma K., Takahashi S., Cruikshank W.W., Jimbow K., Sato N. Immunosuppressive effect on T cell activation by interleukin- 16-cDNA-transfected human squamous cell line. Cell Immunol. 2000, 202:54-60.
11. Gronostajski R.M. Roles of the NFI/CTF gene family in transcription and development. Gene 2000, 249:31-45.
12. 2+ and other cation-transporting ATPases using an oligonucleotide probe derived from the ATP-binding site. J. Biol. Chem. 1988, 263:15032-15040.
13. Hung C.C., Ichimura T., Stevens J.L., Bonventre J.V. Protection of renal epithelial cells against oxidative injury by endoplasmic reticulum stress preconditioning is mediated by ERK1/2 activation. J. Biol. Chem. 2003, 278:29317-29326.
14. Janes S.M., Watt F.M. New roles for integrins in squamous-cell carcinoma. Nat. Rev. Cancer 2006, 6:175-183.
15. Kim Y.J., Kwak C.I., Gu Y.Y., Hwang I.T., Chun J.Y. Annealing control primer system for identification of differentially expressed genes on agarose gels. Biotechniques 2004, 36:424-426. 428, 430.
16. Li A.G., Lu S.L., Han G., Hoot K.E., Wang X.J. Role of TGFbeta in skin inflammation and carcinogenesis. Mol. Carcinog 2006, 45:389-396.
17. Liang S.H., Zhang W., McGrath B.C., Zhang P., Cavener D.R. PERK (eIF2alpha kinase) is required to activate the stress-activated MAPKs and induce the expression of immediate-early genes upon disruption of ER calcium homoeostasis. Biochem. J. 2006, 393:201-209.
18. 2+ pump. J. Biol. Chem. 2001, 276:26737-26740.
19. Lowry D.T., Li L., Hennings H. Thapsigargin, a weak skin tumor promoter, alters the growth and differentiation of mouse keratinocytes in culture. Carcinogenesis 1996, 17:699-706.
20. Lu S.L., Herrington H., Reh D., Weber S., Bornstein S., Wang D., Li A.G., Tang C.F., Siddiqui Y., Nord J., Andersen P., Corless C.L., Wang X.J. Loss of transforming growth factor-beta type II receptor promotes metastatic head-and-neck squamous cell carcinoma. Genes Dev. 2006, 20:1331-1342.
21. Melnikova V.O., Ananthaswamy H.N. Cellular and molecular events leading to the development of skin cancer. Mutat. Res. 2005, 571:91-106.
22. Ohto-Fujita E., Fujita Y., Atomi Y. Analysis of the alphaB-crystallin domain responsible for inhibiting tubulin aggregation. Cell Stress Chaperones 2007, 12:163-171.
23. 2+ ATPase 2 gene silencing promotes cell survival: a potential role for TRPC1 in Darier's disease. Mol. Biol. Cell 2006, 17:4446-4458.
24. 2+-ATPase isoform 2 (SERCA2) gene. J. Biol. Chem. 1999, 274:2556-2562.
25. 2+ pump, predisposes mice to squamous cell tumors via a novel mode of cancer susceptibility. Cancer Res. 2005, 65:8655-8661.
26. Prevarskaya N., Zhang L., Barritt G. TRP channels in cancer. Biochim. Biophys. Acta 2007, 1772:937-946.
27. Rebel H., Mosnier L.O., Berg R.J., Westerman-de Vries A., van Steeg H., van Kranen H.J., de Gruijl F.R. Early p53-positive foci as indicators of tumor risk in ultraviolet-exposed hairless mice: kinetics of induction, effects of DNA repair deficiency, and p53 heterozygosity. Cancer Res. 2001, 61:977-983.
28. 2+ pump, cause Darier disease. Nat. Genet. 1999, 21:271-277.
29. Schubbert S., Shannon K., Bollag G. Hyperactive Ras in developmental disorders and cancer. Nat. Rev. Cancer 2007, 7:295-308.
30. Seger R., Krebs E.G. The MAPK signaling cascade. FASEB J. 1995, 9:726-735.
31. Shchors K., Evan G. Tumor angiogenesis: cause or consequence of cancer?. Cancer Res. 2007, 67:7059-7061.
32. Shimada A., Kano J., Ishiyama T., Okubo C., Iijima T., Morishita Y., Minami Y., Inadome Y., Shu Y., Sugita S., Takeuchi T., Noguchi M. Establishment of an immortalized cell line from a precancerous lesion of lung adenocarcinoma, and genes highly expressed in the early stages of lung adenocarcinoma development. Cancer Sci. 2005, 96:668-675.
33. Theodore A.C., Center D.M., Nicoll J., Fine G., Kornfeld H., Cruikshank W.W. CD4 ligand IL-16 inhibits the mixed lymphocyte reaction. J. Immunol. 1996, 157:1958-1964.
34. 2+-dependent exocytosis in SERCA2(+/-) mice. EMBO J. 2001, 20:2680-2689.